Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 150
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts
‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance
August 2025 Psychedelic Patent Update
Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos
Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale
PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and...
COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...
Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results
atai Life Sciences to Announce Second Quarter 2022 Financial Results and...
BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics
Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study...
FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE
PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada:...
Psychedelic Bulletin #112 – Inside the DEA Challenge; Second Psychedelics Company...
Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines
1
...
149
150
151
...
296
Page 150 of 296